Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Debbie M van Rooijen"'
Autor:
Mariëtte B van Ravenhorst, Gerco den Hartog, Fiona R M van der Klis, Debbie M van Rooijen, Elisabeth A M Sanders, Guy A M Berbers
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0191261 (2018)
Meningococcal infection starts with colonisation of the upper respiratory tract. Mucosal immunity is important for protection against acquisition and subsequent meningococcal carriage. In this study, we assessed salivary antibody levels against menin
Externí odkaz:
https://doaj.org/article/be2604ff8cf5459da29068fc22ebac32
Autor:
Susanne P Stoof, Anne-Marie Buisman, Debbie M van Rooijen, Rianne Boonacker, Fiona R M van der Klis, Elisabeth A M Sanders, Guy A M Berbers
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0138665 (2015)
Antibody levels wane rapidly after Meningococcal serogroup C conjugate (MenCC) vaccination in young children, rendering the need for an adolescent booster dose. It is not clear whether circulating memory B cells are associated with persistence of Men
Externí odkaz:
https://doaj.org/article/6b1b0917fdcf4ce79184dfc75d7a64ed
Autor:
Susanne P Stoof, Fiona R M van der Klis, Debbie M van Rooijen, Mirjam J Knol, Elisabeth A M Sanders, Guy A M Berbers
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100651 (2014)
BACKGROUND: Meningococcal serogroup C (MenC) specific antibody levels decline rapidly after a single primary MenC conjugate (MenCC) vaccination in preschool children. A second MenCC vaccination during (pre)adolescence might attain longer lasting indi
Externí odkaz:
https://doaj.org/article/3eb81c6ebaa3472e9e4abf167951f162
Autor:
Hester E. de Melker, Guy A. M. Berbers, Marjan J.M. Bogaard, Milou Ohm, Debbie M. van Rooijen, Elisabeth A. M. Sanders, Mirjam J. Knol, Fiona R. M. van der Klis, Eric R.A. Vos
Publikováno v:
Vaccine. 40:59-66
Background Meningococcal serogroup C (MenC) vaccination was introduced for 14-month-olds in the Netherlands in 2002, alongside a mass campaign for 1–18 year-olds. Due to an outbreak of serogroup W disease, MenC vaccination was replaced for MenACWY
Autor:
Milou Ohm, Janine J. Wolf, Debbie M. van Rooijen, Linda J. Visser, Willem R. Miellet, Rob Mariman, Krzysztof Trzciński, Anne-Marie Buisman, Fiona R.M. van der Klis, Guy A.M. Berbers, Mirjam J. Knol, Nina M. van Sorge, Gerco den Hartog
Publikováno v:
medRxiv
BackgroundComplement-mediated killing is critical in the defense against meningococci. During a recent outbreak of invasive meningococcal serogroup W disease (IMD-W) in the Netherlands, the predominant isolates belonged to clonal complex (cc) 11, whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abb1344f2c186ce50e024bc959ad6b5c
https://doi.org/10.1101/2022.05.20.22275303
https://doi.org/10.1101/2022.05.20.22275303
Autor:
Jeffrey van Vliet, Debbie M. van Rooijen, Denise Wong, Marjan Bogaard-van Maurik, Hester E. de Melker, Ilse Zutt, Michiel van Boven, Cheyenne C E van Hagen, Lotus L. van den Hoogen, Marije K Verheul, Fiona R. M. van der Klis, Robert S. van Binnendijk, Marjan Kuijer, Alienke J. Wijmenga-Monsuur, Eric R.A. Vos, Gerco den Hartog, Gaby Smit
mRNA- and vector-based vaccines are used at a large scale to prevent COVID-19. We compared Spike S1-specific (S1) IgG antibodies after vaccination with mRNA-based (Comirnaty, Spikevax) or vector-based (Janssen, Vaxzevria) vaccines, using samples from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f16283f15cdda45c6950a20580b38fd3
https://doi.org/10.1101/2021.10.25.21265467
https://doi.org/10.1101/2021.10.25.21265467
Autor:
Axel A. Bonačić Marinović, Milou Ohm, Guy A. M. Berbers, Elisabeth A. M. Sanders, Anne-Marie Buisman, Mariëtte B. van Ravenhorst, Marieke van der Heiden, Debbie M. van Rooijen
Publikováno v:
Vaccines, Vol 8, Iss 624, p 624 (2020)
Vaccines
Volume 8
Issue 4
Vaccines
Volume 8
Issue 4
Neisseria meningitidis is often asymptomatically carried in the nasopharynx but may cause invasive meningococcal disease, leading to morbidity and mortality. Meningococcal conjugate vaccinations induce functional protective antibodies against capsula
Autor:
Milou, Ohm, Debbie M, van Rooijen, Axel A, Bonačić Marinović, Mariëtte B, van Ravenhorst, Marieke, van der Heiden, Anne-Marie, Buisman, Elisabeth A M, Sanders, Guy A M, Berbers
Publikováno v:
Vaccines
Neisseria meningitidis is often asymptomatically carried in the nasopharynx but may cause invasive meningococcal disease, leading to morbidity and mortality. Meningococcal conjugate vaccinations induce functional protective antibodies against capsula
Autor:
Marianne A van Houten, Debbie M. van Rooijen, Patricia Kaaijk, M Alina Nicolaie, Anne-Marie Buisman, Fiona R. M. van der Klis, Rob van Binnendijk
Publikováno v:
Open Forum Infectious Diseases
Background Breakthrough infections of measles and mumps have raised concerns about the duration of vaccine-induced immunity, which might be improved by a third dose of measles-mumps-rubella vaccine (MMR3). Methods Here we compared (IgG) antibody leve
Autor:
Marjan van Maurik, Axel A. Bonačić Marinović, Mariëtte B. van Ravenhorst, Debbie M. van Rooijen, Elisabeth A. M. Sanders, Fiona R. M. van der Klis, Guy A. M. Berbers, Susanne P. Stoof
Publikováno v:
Vaccine, 34(50), 6309-6315. Elsevier BV
van Ravenhorst, M B, Marinovic, A B, van der Klis, F R M, van Rooijen, D M, van Maurik, M, Stoof, S P, Sanders, E A M & Berbers, G A M 2016, ' Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination ', Vaccine, vol. 34, no. 50, pp. 6309-6315 . https://doi.org/10.1016/j.vaccine.2016.10.049
Vaccine, 34(50), 6309. Elsevier BV
van Ravenhorst, M B, Marinovic, A B, van der Klis, F R M, van Rooijen, D M, van Maurik, M, Stoof, S P, Sanders, E A M & Berbers, G A M 2016, ' Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination ', Vaccine, vol. 34, no. 50, pp. 6309-6315 . https://doi.org/10.1016/j.vaccine.2016.10.049
Vaccine, 34(50), 6309. Elsevier BV
Introduction. Due to waning immunity, infant vaccination with meningococcal serogroup C conjugated (MenCC) vaccines is insufficient to maintain long-term individual protection. Adolescent booster vaccination is thought to offer direct protection agai